Victoria Juskaite
Principal Scientist Therapeutics Avacta
Victoria Juskaite is a Principal Scientist at Avacta, where she leads the Assay Team supporting in vitro model development, as well as mechanistic and translational studies that inform clinical development. She completed her PhD in Molecular and Cell Biology at Imperial College London and later specialised in immunology and cancer biology. With over eight years of industry experience in drug development and preclinical modelling, including a previous role at LifeArc, Victoria brings strong translational expertise to oncology therapeutic development.
Seminars
Thursday 4th December 2025
Optimising Spheroid Co-Cultures & PDX models to Empower the Translation of FAP-Enabled pre|CISION®-Peptide Drug Conjugates
5:00 pm
- Highlighting the background of fibroblast activation protein (FAP)-enabled pre|CISION®-peptide drug conjugates (PDCs) and the rationale for model selection
- Sharing best practices for developing co-cultures of tumour cells and human primary FAP+ fibroblasts to assess bystander activity of PDCs in physiologically relevant systems
- Characterising PDCs using CDX, PDX models, and spheroid co-cultures to better understand their mechanism of action
